INDP Stock Analysis: Buy, Sell, or Hold?
INDP - Indaptus Therapeutics, Inc. Common Stock
$3.17
-0.09 (-2.76%)
▼
5d:
-7.85%
30d:
+78.09%
90d:
+38.43%
HOLD
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 13, 2026
13d
Get Alerted When INDP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INDP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: INDP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: INDP is currently trading at $3.17, which is considered extended relative to its 30-day fair value range of $1.65 to $3.16.
Technical Outlook: Technically, INDP is showing sideways momentum. Immediate support is located at $2.22, while resistance sits at $3.84.
Market Sentiment: INDP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+206.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INDP is showing sideways momentum. Immediate support is located at $2.22, while resistance sits at $3.84.
Market Sentiment: INDP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.00 (+206.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.65 -
$3.16
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: Trading 206.7% below Wall St target ($10.00)
- CAUTION: 5-day price weakness (-7.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.65 -
$3.16
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.22
Resistance Level
$3.84
Current Trend
Sideways
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.73
Wall Street Target
$10.00
(+206.7%)
Share & Embed Analysis
Last updated: April 29, 2026 9:57 AM ET
Data refreshes hourly during market hours. Next update: 10:57 AM
Data refreshes hourly during market hours. Next update: 10:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INDP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 52 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$224 | 64 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 49 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$107 | 50 HOLD |
